Should you buy Rocket Lab USA stock now?
The technical signal for Rocket Lab USA is currently Hold. Rocket Lab USA trades at $75.06 as of Oct 7, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 1.173 with rising momentum (signal: 0.303); RSI is at 59.8 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $109.37 points to 45.7% upside. This is a technical observation based on current data, not investment advice.
What is the price target for Rocket Lab USA stock?
The average analyst price target for Rocket Lab USA is $109.37. The current price is $75.06, which gives an upside of 45.7%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $98.43 and $120.31.
Is Rocket Lab USA a dividend stock?
No, Rocket Lab USA does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Rocket Lab USA stock?
Rocket Lab USA is rated as a stock in the risk category Extremely speculative. the annual standard deviation is 93.4%, which classifies the stock as Extremely speculative.
Is Rocket Lab USA overvalued?
No, Rocket Lab USA is considered undervalued based on the analyst price target (45.7% upside). Rocket Lab USA has the following valuation ratios: a P/S ratio of 57.9, a P/B ratio of 12.9. The analyst price target suggests that the stock is undervalued by 45.7%.
Is Rocket Lab USA overbought?
No, Rocket Lab USA is not overbought. RSI is at 59.8 (neutral zone). The technical indicators show: RSI is at 59.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 9.3% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Rocket Lab USA earnings report?
Rocket Lab USA reports its next earnings on November 9, 2026. The stock currently trades at $75.06.
Is Rocket Lab USA shorted?
Yes, Rocket Lab USA is shorted with 7.3% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Rocket Lab USA stock?
No, insiders are not buying Rocket Lab USA shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 9 sales. On a net basis, 25,420,853 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 131,369,933 $ sold. Active sellers include Spice Adam C., Klein Frank, Kampani Arjun and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Rocket Lab USA a good stock?
Based on our total score, Rocket Lab USA is rated as a disastrous stock with a total score of 12 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 5/100, Quality: 15/100, Momentum: 18/100. In addition: analysts see 45.7% upside to the price target; technical signal: Hold. Whether Rocket Lab USA is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Rocket Lab USA stock?
The outlook for Rocket Lab USA based on current data: the average analyst price target is $109.37 (+45.7%); the next earnings report is due on Nov 9, 2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Rocket Lab USA stock rising?
Rocket Lab USA is rising right now. The technical indicators show: the price is 9.3% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 7.3% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Rocket Lab USA go?
The average analyst price target for Rocket Lab USA is $109.37, which corresponds to a potential gain of 45.7% from the current price of $75.06. The stock has traded between $37.57 and $151.00 over the last 52 weeks. The price is 50.3% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Rocket Lab USA fall?
The stock has traded as low as $37.57 over the last 52 weeks — that is 49.9% below the current price of $75.06. The biggest decline (drawdown) in the same period was 75.1% from high to low. Within a year, the price typically swings about ±93.4% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Rocket Lab USA do?
**What the company does and how it makes money**
Rocket Lab Corporation (RKLB.us) builds space equipment and launches satellites into orbit for customers. It earns money in two main ways: by launching satellites for governments and businesses, and by designing and building sa... The company belongs to the Industrials sector, more specifically the Aerospace & Defense industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Rocket Lab USA as an investment.
Did Rocket Lab USA raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Rocket Lab USA. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Rocket Lab USA making money or losing money?
No, Rocket Lab USA is currently not making money — the company is losing money with a negative profit margin of -21.5%, a substantial loss. That means the business loses money on every dollar of revenue. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Rocket Lab USA go bankrupt?
The bankruptcy risk of Rocket Lab USA is rated as low. Altman Z2 (a model for assessing financial distress) is 7.83 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 3 — which is weak. Debt relative to equity is 210% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Rocket Lab USA have a lot of debt?
Yes, Rocket Lab USA has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 210%. For the industrials sector, anything above 200% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Industrial companies often sit at 100-200% because of heavy production assets and long order books. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
